Page last updated: 2024-08-23

piperacillin and Carcinoma, Non-Small Cell Lung

piperacillin has been researched along with Carcinoma, Non-Small Cell Lung in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Cho, SY; Chung, YN; Heo, WY; Huh, HJ; Kang, OK; Lee, JK; Lee, NY; Sung, DH; Yoo, IY1
Cipelli, R; Dangoor, A; Hodgson, M; Lester, JF; Naik, J; Newsom-Davis, T; Patel, A; Shah, R; Summerhayes, M; Talbot, D; Talbot, T1

Other Studies

2 other study(ies) available for piperacillin and Carcinoma, Non-Small Cell Lung

ArticleYear
First Case of Bacteremia Caused by Coprobacillus catenaformis.
    Annals of laboratory medicine, 2020, Volume: 40, Issue:5

    Topics: Aged; Anti-Bacterial Agents; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Female; Firmicutes; Gram-Positive Bacterial Infections; Humans; Laminectomy; Pedicle Screws; Piperacillin; Spinal Cord; Tazobactam

2020
The burden of neutropenic sepsis in patients with advanced non-small cell lung cancer treated with single-agent docetaxel: A retrospective study.
    Lung cancer (Amsterdam, Netherlands), 2017, Volume: 113

    Topics: Aged; Anti-Bacterial Agents; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cost of Illness; Docetaxel; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Outcome Assessment, Health Care; Penicillanic Acid; Piperacillin; Retrospective Studies; Sepsis; Taxoids; Tazobactam

2017